Cross-reactive and cross-neutralizing activity of human mumps antibodies against a novel mumps virus from bats

Journal of Infectious Diseases

Volumn 215, Issue 2, 2017, Pages 209-213

  Beaty, Shannon M ^a   Nachbagauer, Raffael ^a   Hirsh, Ariana ^a   Vigant, Frederic ^a   Duehr, James ^a   Azarm, Kristopher D ^a   Stelfox, Alice J ^c   Bowden, Thomas A ^c   Paul Duprex, W ^b   Krammer, Florian ^a   Lee, Benhur ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

cross reactive antibodies; Mumps virus; neutralizing antibodies; Viral envelope proteins; Zoonoses

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANIMAL; BAGG ALBINO MOUSE; BAT; BLOOD; CROSS REACTION; FEMALE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; MUMPS VIRUS; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHIROPTERA; CROSS REACTIONS; FEMALE; HUMANS; MICE, INBRED BALB C; MIDDLE AGED; MUMPS VIRUS; YOUNG ADULT;

EID: 85021857304     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw534     Document Type: Article

References (14)

1. Hviid A, Rubin S, Möhlemann K. Mumps. Lancet 2008; 371:932-44.
2. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: Are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis 2008; 47:1458-67.
3. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: A global review. Bull World Health Organ 1999; 66:509.
4. Drexler JF, Corman VM, Möller MA, et al. Bats host major mammalian paramyxoviruses. Nat Commun 2012; 3:796.
5. Kruger N, Hoffmann M, Drexler JF, et al. Functional properties and genetic relatedness of the fusion and hemagglutinin-neuraminidase proteins of a mumps virus-like bat virus. J Virol 2015; 89:4539-48.
6. Yun T, Park A, Hill TE, et al. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-Time monitoring of viral spread in small animal models of henipavirus infection. J Virol 2015; 89:1242-53.
7. Krammer F, Margine I, Tan GS, Pica N, Krause JC, Palese P. A carboxyterminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant Hemagglutinin substrates. PLoS One 2012; 7: e43603.
8. Margine I, Palese P, Krammer F. Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. J Vis Exp 2013; (81):e51112.
9. Nachbagauer R, Wohlbold TJ, Hirsh A, et al. Induction of broadly reactive antihemagglutinin stalk antibodies by an H5N1 vaccine in humans. J Virol 2014; 88:13260-8.
10. Möhlemann K. The molecular epidemiology of mumps virus. Infect Genet Evol 2004; 4:215-9.
11. Köhnel K, Jarchau T, Wolf E, et al. The VASP tetramerization domain is a righthanded coiled coil based on a 15-residue repeat. Proc Natl Acad Sci U S A 2004; 101:17027-32.
12. Yuan P, Thompson TB, Wurzburg BA, Paterson RG, Lamb RA, Jardetzky TS. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 2005; 13:803-15.
13. Orvell C, Alsheikhly AR, Kalantari M, Johansson B. Characterization of genotypespecific epitopes of the HN protein of mumps virus. J Gen Virol 1997; 78: 3187-93.
14. Katoh H, Kubota T, Ihara T, Maeda K, Takeda M, Kidokoro M. Cross-neutralization between human and African bat mumps viruses. Emerg Infect Dis 2016; 22:703-6.